S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.011 SEK Market Closed
Market Cap: 10.8m SEK
Have any thoughts about
S2Medical AB (publ)?
Write Note

S2Medical AB (publ)
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

S2Medical AB (publ)
Cash & Cash Equivalents Peer Comparison

Comparables:
O
OSSD
XVIVO
D
DOXA
BACTI B
V
VIMIAN

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
S
S2Medical AB (publ)
STO:S2M
Cash & Cash Equivalents
kr1.4m
CAGR 3-Years
-48%
CAGR 5-Years
-45%
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Cash & Cash Equivalents
kr165.9m
CAGR 3-Years
50%
CAGR 5-Years
64%
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Cash & Cash Equivalents
kr450m
CAGR 3-Years
17%
CAGR 5-Years
18%
CAGR 10-Years
23%
D
Doxa AB
STO:DOXA
Cash & Cash Equivalents
kr11.8m
CAGR 3-Years
121%
CAGR 5-Years
3%
CAGR 10-Years
10%
Bactiguard Holding AB
STO:BACTI B
Cash & Cash Equivalents
kr123.2m
CAGR 3-Years
132%
CAGR 5-Years
131%
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Cash & Cash Equivalents
€41.2m
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is S2Medical AB (publ)'s Cash & Cash Equivalents?
Cash & Cash Equivalents
1.4m SEK

Based on the financial report for Jun 30, 2024, S2Medical AB (publ)'s Cash & Cash Equivalents amounts to 1.4m SEK.

What is S2Medical AB (publ)'s Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-45%

Over the last year, the Cash & Cash Equivalents growth was -17%. The average annual Cash & Cash Equivalents growth rates for S2Medical AB (publ) have been -48% over the past three years , -45% over the past five years .

Back to Top